Blood Pressure Management and Evolution of Thrombolysis-associated Intracerebral Hemorrhage in Acute Ischemic Stroke
Background There is limited knowledge on the radiographic features of thrombolysis-induced hemorrhage. The factors that influence early hematoma expansion have not been elucidated. Methods Patients presenting with a symptomatic intracerebral hemorrhage (ICH) as a result of intravenous (IV) thromboly...
Gespeichert in:
Veröffentlicht in: | Journal of stroke and cerebrovascular diseases 2012-11, Vol.21 (8), p.852-859 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 859 |
---|---|
container_issue | 8 |
container_start_page | 852 |
container_title | Journal of stroke and cerebrovascular diseases |
container_volume | 21 |
creator | Mokin, Maxim, MD, PhD Kass-Hout, Tareq, MD Kass-Hout, Omar, MD Zivadinov, Robert, MD, PhD Mehta, Bijal, MD |
description | Background There is limited knowledge on the radiographic features of thrombolysis-induced hemorrhage. The factors that influence early hematoma expansion have not been elucidated. Methods Patients presenting with a symptomatic intracerebral hemorrhage (ICH) as a result of intravenous (IV) thrombolysis with tissue plasminogen activator (tPA) for acute ischemic stroke and had noncontrast computed tomographic (CT) scans of the head were included in this retrospective study. Calculation of hematoma volumes was obtained. Analysis of covariance was used to evaluate for the effect of baseline blood pressure (BP) on initial hematoma volume and further growth. Results Of 267 patients who were treated with intravenous tPA for acute ischemic stroke at our facility between January 1, 2005 and December 31, 2009, 17 patients developed symptomatic ICH and were included in the final analysis. There was a positive correlation between baseline level of systolic BP after thrombolysis and initial hematoma volume (r = 0.46; P = .03) but not for the diastolic BP (r = 0.07; P = .40). There was a significant increase in mean hematoma volume expansion when comparing results between the first and second CT scans (median 9 hours, 22 minutes; 14.9 ± 19.6 cm3 to 26.0 ± 26.7 cm3 ; P = .04). There was also a negative association between the reduction of systolic BP and hematoma growth (r = -0.67; P = .02), but no correlation with change in diastolic BP (r = -0.22; P = .28). Conclusions Once diagnosed, thrombolysis-induced symptomatic ICH undergoes significant early expansion in size. Systolic BP may play a role in hematoma expansion. |
doi_str_mv | 10.1016/j.jstrokecerebrovasdis.2011.05.006 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1139617955</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1052305711001133</els_id><sourcerecordid>1139617955</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-c99a6274eff98f8732d4e921b0d6d5b3efe4abed85f6c90ffabb2f5cc344ff723</originalsourceid><addsrcrecordid>eNqVkk1v1DAQhiMEoqXwF5CPCCnBH3E-Lkht1dKVFoHUcrYce8w6TeziSVbaf0_SbTkgLpw8h1fPjB-9WfaR0YJRVn3qix6nFO_BQIIuxb1G67HglLGCyoLS6kV2yqTgeSMZe7nMVPJcUFmfZG8Qe7oEZSNfZyec1VQ0dXOaTRdDjJZ8T4A4JyBfddA_YYQwER0sudrHYZ58DCQ6crdLcezicECPuUaMxusJLNmEKenjTXogNzDGlHYLhfhAzs08Admg2cHoDbl9vP9t9srpAeHd03uW_bi-uru8ybffvmwuz7e5kVxOuWlbXfG6BOfaxjW14LaElrOO2srKToCDUndgG-kq01LndNdxJ40RZelczcVZ9uHIfUjx1ww4qdGjgWHQAeKMijHRVqxupVyiF8eoSRExgVMPyY86HRSjarWvevUv-2q1r6hUi_0F8v5p39yNYP8gnnUvge0xAMuv9x6SQuMhGLA-gZmUjf7_9n3-C2cGH7zRwz0cAPs4p7D4VUwhV1Tdrn1Y68DYWgUhxG_V4LzY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1139617955</pqid></control><display><type>article</type><title>Blood Pressure Management and Evolution of Thrombolysis-associated Intracerebral Hemorrhage in Acute Ischemic Stroke</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Mokin, Maxim, MD, PhD ; Kass-Hout, Tareq, MD ; Kass-Hout, Omar, MD ; Zivadinov, Robert, MD, PhD ; Mehta, Bijal, MD</creator><creatorcontrib>Mokin, Maxim, MD, PhD ; Kass-Hout, Tareq, MD ; Kass-Hout, Omar, MD ; Zivadinov, Robert, MD, PhD ; Mehta, Bijal, MD</creatorcontrib><description>Background There is limited knowledge on the radiographic features of thrombolysis-induced hemorrhage. The factors that influence early hematoma expansion have not been elucidated. Methods Patients presenting with a symptomatic intracerebral hemorrhage (ICH) as a result of intravenous (IV) thrombolysis with tissue plasminogen activator (tPA) for acute ischemic stroke and had noncontrast computed tomographic (CT) scans of the head were included in this retrospective study. Calculation of hematoma volumes was obtained. Analysis of covariance was used to evaluate for the effect of baseline blood pressure (BP) on initial hematoma volume and further growth. Results Of 267 patients who were treated with intravenous tPA for acute ischemic stroke at our facility between January 1, 2005 and December 31, 2009, 17 patients developed symptomatic ICH and were included in the final analysis. There was a positive correlation between baseline level of systolic BP after thrombolysis and initial hematoma volume (r = 0.46; P = .03) but not for the diastolic BP (r = 0.07; P = .40). There was a significant increase in mean hematoma volume expansion when comparing results between the first and second CT scans (median 9 hours, 22 minutes; 14.9 ± 19.6 cm3 to 26.0 ± 26.7 cm3 ; P = .04). There was also a negative association between the reduction of systolic BP and hematoma growth (r = -0.67; P = .02), but no correlation with change in diastolic BP (r = -0.22; P = .28). Conclusions Once diagnosed, thrombolysis-induced symptomatic ICH undergoes significant early expansion in size. Systolic BP may play a role in hematoma expansion.</description><identifier>ISSN: 1052-3057</identifier><identifier>EISSN: 1532-8511</identifier><identifier>DOI: 10.1016/j.jstrokecerebrovasdis.2011.05.006</identifier><identifier>PMID: 21703878</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute stroke ; Aged ; Aged, 80 and over ; Antihypertensive Agents - therapeutic use ; blood pressure ; Blood Pressure - drug effects ; Brain Ischemia - drug therapy ; Cardiovascular ; Cerebral Hemorrhage - chemically induced ; Cerebral Hemorrhage - diagnostic imaging ; Cerebral Hemorrhage - physiopathology ; Disease Progression ; Female ; Fibrinolytic Agents - administration & dosage ; Fibrinolytic Agents - adverse effects ; Hematoma - chemically induced ; Hematoma - diagnostic imaging ; Hematoma - physiopathology ; Humans ; intracerebral hemorrhage ; Male ; Middle Aged ; Neurology ; Retrospective Studies ; Stroke - drug therapy ; Systole ; thrombolysis ; Thrombolytic Therapy - adverse effects ; Time Factors ; tissue plasminogen activator ; Tissue Plasminogen Activator - administration & dosage ; Tissue Plasminogen Activator - adverse effects ; Tomography, X-Ray Computed</subject><ispartof>Journal of stroke and cerebrovascular diseases, 2012-11, Vol.21 (8), p.852-859</ispartof><rights>National Stroke Association</rights><rights>2012 National Stroke Association</rights><rights>Copyright © 2012 National Stroke Association. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c525t-c99a6274eff98f8732d4e921b0d6d5b3efe4abed85f6c90ffabb2f5cc344ff723</citedby><cites>FETCH-LOGICAL-c525t-c99a6274eff98f8732d4e921b0d6d5b3efe4abed85f6c90ffabb2f5cc344ff723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1052305711001133$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21703878$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mokin, Maxim, MD, PhD</creatorcontrib><creatorcontrib>Kass-Hout, Tareq, MD</creatorcontrib><creatorcontrib>Kass-Hout, Omar, MD</creatorcontrib><creatorcontrib>Zivadinov, Robert, MD, PhD</creatorcontrib><creatorcontrib>Mehta, Bijal, MD</creatorcontrib><title>Blood Pressure Management and Evolution of Thrombolysis-associated Intracerebral Hemorrhage in Acute Ischemic Stroke</title><title>Journal of stroke and cerebrovascular diseases</title><addtitle>J Stroke Cerebrovasc Dis</addtitle><description>Background There is limited knowledge on the radiographic features of thrombolysis-induced hemorrhage. The factors that influence early hematoma expansion have not been elucidated. Methods Patients presenting with a symptomatic intracerebral hemorrhage (ICH) as a result of intravenous (IV) thrombolysis with tissue plasminogen activator (tPA) for acute ischemic stroke and had noncontrast computed tomographic (CT) scans of the head were included in this retrospective study. Calculation of hematoma volumes was obtained. Analysis of covariance was used to evaluate for the effect of baseline blood pressure (BP) on initial hematoma volume and further growth. Results Of 267 patients who were treated with intravenous tPA for acute ischemic stroke at our facility between January 1, 2005 and December 31, 2009, 17 patients developed symptomatic ICH and were included in the final analysis. There was a positive correlation between baseline level of systolic BP after thrombolysis and initial hematoma volume (r = 0.46; P = .03) but not for the diastolic BP (r = 0.07; P = .40). There was a significant increase in mean hematoma volume expansion when comparing results between the first and second CT scans (median 9 hours, 22 minutes; 14.9 ± 19.6 cm3 to 26.0 ± 26.7 cm3 ; P = .04). There was also a negative association between the reduction of systolic BP and hematoma growth (r = -0.67; P = .02), but no correlation with change in diastolic BP (r = -0.22; P = .28). Conclusions Once diagnosed, thrombolysis-induced symptomatic ICH undergoes significant early expansion in size. Systolic BP may play a role in hematoma expansion.</description><subject>Acute stroke</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>blood pressure</subject><subject>Blood Pressure - drug effects</subject><subject>Brain Ischemia - drug therapy</subject><subject>Cardiovascular</subject><subject>Cerebral Hemorrhage - chemically induced</subject><subject>Cerebral Hemorrhage - diagnostic imaging</subject><subject>Cerebral Hemorrhage - physiopathology</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Fibrinolytic Agents - administration & dosage</subject><subject>Fibrinolytic Agents - adverse effects</subject><subject>Hematoma - chemically induced</subject><subject>Hematoma - diagnostic imaging</subject><subject>Hematoma - physiopathology</subject><subject>Humans</subject><subject>intracerebral hemorrhage</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Retrospective Studies</subject><subject>Stroke - drug therapy</subject><subject>Systole</subject><subject>thrombolysis</subject><subject>Thrombolytic Therapy - adverse effects</subject><subject>Time Factors</subject><subject>tissue plasminogen activator</subject><subject>Tissue Plasminogen Activator - administration & dosage</subject><subject>Tissue Plasminogen Activator - adverse effects</subject><subject>Tomography, X-Ray Computed</subject><issn>1052-3057</issn><issn>1532-8511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkk1v1DAQhiMEoqXwF5CPCCnBH3E-Lkht1dKVFoHUcrYce8w6TeziSVbaf0_SbTkgLpw8h1fPjB-9WfaR0YJRVn3qix6nFO_BQIIuxb1G67HglLGCyoLS6kV2yqTgeSMZe7nMVPJcUFmfZG8Qe7oEZSNfZyec1VQ0dXOaTRdDjJZ8T4A4JyBfddA_YYQwER0sudrHYZ58DCQ6crdLcezicECPuUaMxusJLNmEKenjTXogNzDGlHYLhfhAzs08Admg2cHoDbl9vP9t9srpAeHd03uW_bi-uru8ybffvmwuz7e5kVxOuWlbXfG6BOfaxjW14LaElrOO2srKToCDUndgG-kq01LndNdxJ40RZelczcVZ9uHIfUjx1ww4qdGjgWHQAeKMijHRVqxupVyiF8eoSRExgVMPyY86HRSjarWvevUv-2q1r6hUi_0F8v5p39yNYP8gnnUvge0xAMuv9x6SQuMhGLA-gZmUjf7_9n3-C2cGH7zRwz0cAPs4p7D4VUwhV1Tdrn1Y68DYWgUhxG_V4LzY</recordid><startdate>20121101</startdate><enddate>20121101</enddate><creator>Mokin, Maxim, MD, PhD</creator><creator>Kass-Hout, Tareq, MD</creator><creator>Kass-Hout, Omar, MD</creator><creator>Zivadinov, Robert, MD, PhD</creator><creator>Mehta, Bijal, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121101</creationdate><title>Blood Pressure Management and Evolution of Thrombolysis-associated Intracerebral Hemorrhage in Acute Ischemic Stroke</title><author>Mokin, Maxim, MD, PhD ; Kass-Hout, Tareq, MD ; Kass-Hout, Omar, MD ; Zivadinov, Robert, MD, PhD ; Mehta, Bijal, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-c99a6274eff98f8732d4e921b0d6d5b3efe4abed85f6c90ffabb2f5cc344ff723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Acute stroke</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>blood pressure</topic><topic>Blood Pressure - drug effects</topic><topic>Brain Ischemia - drug therapy</topic><topic>Cardiovascular</topic><topic>Cerebral Hemorrhage - chemically induced</topic><topic>Cerebral Hemorrhage - diagnostic imaging</topic><topic>Cerebral Hemorrhage - physiopathology</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Fibrinolytic Agents - administration & dosage</topic><topic>Fibrinolytic Agents - adverse effects</topic><topic>Hematoma - chemically induced</topic><topic>Hematoma - diagnostic imaging</topic><topic>Hematoma - physiopathology</topic><topic>Humans</topic><topic>intracerebral hemorrhage</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Retrospective Studies</topic><topic>Stroke - drug therapy</topic><topic>Systole</topic><topic>thrombolysis</topic><topic>Thrombolytic Therapy - adverse effects</topic><topic>Time Factors</topic><topic>tissue plasminogen activator</topic><topic>Tissue Plasminogen Activator - administration & dosage</topic><topic>Tissue Plasminogen Activator - adverse effects</topic><topic>Tomography, X-Ray Computed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mokin, Maxim, MD, PhD</creatorcontrib><creatorcontrib>Kass-Hout, Tareq, MD</creatorcontrib><creatorcontrib>Kass-Hout, Omar, MD</creatorcontrib><creatorcontrib>Zivadinov, Robert, MD, PhD</creatorcontrib><creatorcontrib>Mehta, Bijal, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of stroke and cerebrovascular diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mokin, Maxim, MD, PhD</au><au>Kass-Hout, Tareq, MD</au><au>Kass-Hout, Omar, MD</au><au>Zivadinov, Robert, MD, PhD</au><au>Mehta, Bijal, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Blood Pressure Management and Evolution of Thrombolysis-associated Intracerebral Hemorrhage in Acute Ischemic Stroke</atitle><jtitle>Journal of stroke and cerebrovascular diseases</jtitle><addtitle>J Stroke Cerebrovasc Dis</addtitle><date>2012-11-01</date><risdate>2012</risdate><volume>21</volume><issue>8</issue><spage>852</spage><epage>859</epage><pages>852-859</pages><issn>1052-3057</issn><eissn>1532-8511</eissn><abstract>Background There is limited knowledge on the radiographic features of thrombolysis-induced hemorrhage. The factors that influence early hematoma expansion have not been elucidated. Methods Patients presenting with a symptomatic intracerebral hemorrhage (ICH) as a result of intravenous (IV) thrombolysis with tissue plasminogen activator (tPA) for acute ischemic stroke and had noncontrast computed tomographic (CT) scans of the head were included in this retrospective study. Calculation of hematoma volumes was obtained. Analysis of covariance was used to evaluate for the effect of baseline blood pressure (BP) on initial hematoma volume and further growth. Results Of 267 patients who were treated with intravenous tPA for acute ischemic stroke at our facility between January 1, 2005 and December 31, 2009, 17 patients developed symptomatic ICH and were included in the final analysis. There was a positive correlation between baseline level of systolic BP after thrombolysis and initial hematoma volume (r = 0.46; P = .03) but not for the diastolic BP (r = 0.07; P = .40). There was a significant increase in mean hematoma volume expansion when comparing results between the first and second CT scans (median 9 hours, 22 minutes; 14.9 ± 19.6 cm3 to 26.0 ± 26.7 cm3 ; P = .04). There was also a negative association between the reduction of systolic BP and hematoma growth (r = -0.67; P = .02), but no correlation with change in diastolic BP (r = -0.22; P = .28). Conclusions Once diagnosed, thrombolysis-induced symptomatic ICH undergoes significant early expansion in size. Systolic BP may play a role in hematoma expansion.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>21703878</pmid><doi>10.1016/j.jstrokecerebrovasdis.2011.05.006</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1052-3057 |
ispartof | Journal of stroke and cerebrovascular diseases, 2012-11, Vol.21 (8), p.852-859 |
issn | 1052-3057 1532-8511 |
language | eng |
recordid | cdi_proquest_miscellaneous_1139617955 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Acute stroke Aged Aged, 80 and over Antihypertensive Agents - therapeutic use blood pressure Blood Pressure - drug effects Brain Ischemia - drug therapy Cardiovascular Cerebral Hemorrhage - chemically induced Cerebral Hemorrhage - diagnostic imaging Cerebral Hemorrhage - physiopathology Disease Progression Female Fibrinolytic Agents - administration & dosage Fibrinolytic Agents - adverse effects Hematoma - chemically induced Hematoma - diagnostic imaging Hematoma - physiopathology Humans intracerebral hemorrhage Male Middle Aged Neurology Retrospective Studies Stroke - drug therapy Systole thrombolysis Thrombolytic Therapy - adverse effects Time Factors tissue plasminogen activator Tissue Plasminogen Activator - administration & dosage Tissue Plasminogen Activator - adverse effects Tomography, X-Ray Computed |
title | Blood Pressure Management and Evolution of Thrombolysis-associated Intracerebral Hemorrhage in Acute Ischemic Stroke |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T13%3A18%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Blood%20Pressure%20Management%20and%20Evolution%20of%20Thrombolysis-associated%20Intracerebral%20Hemorrhage%20in%20Acute%20Ischemic%20Stroke&rft.jtitle=Journal%20of%20stroke%20and%20cerebrovascular%20diseases&rft.au=Mokin,%20Maxim,%20MD,%20PhD&rft.date=2012-11-01&rft.volume=21&rft.issue=8&rft.spage=852&rft.epage=859&rft.pages=852-859&rft.issn=1052-3057&rft.eissn=1532-8511&rft_id=info:doi/10.1016/j.jstrokecerebrovasdis.2011.05.006&rft_dat=%3Cproquest_cross%3E1139617955%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1139617955&rft_id=info:pmid/21703878&rft_els_id=1_s2_0_S1052305711001133&rfr_iscdi=true |